Vasoconstriction of porcine left anterior descending coronary artery by ecstasy and cathinone is not an indirect sympathomimetic effect

Vascular Pharmacology

Volumn 47, Issue 1, 2007, Pages 10-17

  Baker, Kathryn E ^a   Herbert, Amy A ^a   Broadley, Kenneth J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Cathinone; Ecstasy; Noradrenaline; Pig coronary artery; Vasoconstriction

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; BRADYKININ; CARBON DIOXIDE; CATHINONE; COCAINE; NORADRENALIN; OXYGEN; PRAZOSIN; PROPRANOLOL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CARDIOVASCULAR EFFECT; CATHA EDULIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DESENSITIZATION; DRUG INHIBITION; DRUG MECHANISM; INTRINSIC SYMPATHOMIMETIC ACTIVITY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; SWINE; TACHYPHYLAXIS; VASOCONSTRICTION;

ALKALOIDS; ANIMALS; COCAINE; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NOREPINEPHRINE; PRAZOSIN; SWINE; SYMPATHOMIMETICS; VASOCONSTRICTION;

EID: 34249299374     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2007.03.001     Document Type: Article

References (56)

1. Al-Motarreb A., Al-Kebsi M., Al-Adhi B., and Broadley K.J. Khat chewing and acute myocardial infarction. Heart 87 (2002) 279-280
2. Al-Motarreb A., Baker K., and Broadley K.J. Khat: pharmacological and medical aspects and its social use in Yemen. Phytother. Res. 16 (2002) 403-413
3. Al-Motarreb A.L., and Broadley K.J. Coronary and aortic vasoconstriction by cathinone, the active constituent of khat. Auton. Autacoid Pharmacol. 23 (2003) 319-326
4. Al-Motarreb A., Briancon S., Al-Jaber N., Al-Adhi B., Al-Jailani F., Salek M.S., and Broadley K.J. Khat chewing is a risk factor for acute myocardial infarction: a case-control study. Br. J. Clin. Pharmacol. 59 (2005) 574-581
5. Al-Sahli W., Ahmad H., Kheradmand F., Connolly C., and Docherty J.R. Effects of methylenedioxymethamphetamine on noradrenaline-evoked contractions of rat right ventricle and small mesenteric artery. Eur. J. Pharmacol. 422 (2001) 169-174
6. 1-receptors. Br. J. Pharmacol. 138 (2003) 166
7. 2online, 054P.)
8. Bedford Russell A.R., Schwartz R.H., and Dawling S. Accidental ingestion of ecstasy (of 3,4-methylenedioxymethamphetamine). Arch. Dis. Child. 67 (1992) 1114-1115
9. Bell J.I., Yee R., Cook D.A., and Paton D.M. Properties of PMA. Can. Med. J. 111 (1974) 388
10. Brenneisen R., Fisch H.-U., Koelbing U., Geisshusler S., and Kalix P. Amphetamine-like effects in humans of the khat alkaloid cathinone. Br. J. Clin. Pharmacol. 30 (1990) 825-828
11. Broadley K.J. Autonomic Pharmacology (1996), Taylor and Francis, London
12. Bunzow J.R., Sonders M.S., Arttamangkul S., Harrison L.M., Zhang G., Quigley D.I., Darland T., Suchland K.L., Pasumamula S., Kennedy J.L., Olson S.B., Magenis E., Amara S.G., and Grandy D.K. Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol. Pharmacol. 60 (2001) 1181-1188
13. Cami J., Farre M., Mas M., Roset P.N., Poudevida S., Mas A., San L., and De La Torre R. Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects. J. Clin. Psychopharmacol. 20 (2000) 455-466
14. Coore J.R. A fatal trip with ecstasy: a case of 3,4-methylenedioxymethamphetamine/3,4-methylenedioxyamphetamine toxicity. J. R. Soc. Med. 89 (1996) 51-52P
15. Cohen R.A., Zitnay K.M., Weisbrod R.M., and Tesfamariam B. Influence of the endothelium on tone and the response of isolated pig coronary artery to norepinephrine. J. Pharmacol. Exp.Ther. 244 (1988) 550-555
16. Condon, J., Smith, N., 2003. Prevalence of drug use: key findings from the 2002/2003 British Crime Survey. Home Office Report number 229, Research, Development and Statistics Directorate.
17. Darvesh A.S., Yamamoto B.K., and Gudelsky G.A. Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain. J. Pharmacol. Exp. Ther. 312 (2005) 694-701
18. Davison D., and Parrott A.C. Ecstasy (MDMA) in recreational users: self reported psychological and physiological effects. Hum. Psychopharmacol. 12 (1997) 221-226
19. Dowling G.P., Mcdonough E.T., and Bost R.O. Eve and ecstasy, a report of five deaths associated with the use of MDEA and MDMA. JAMA 257 (1987) 1615-1617
20. Fitzgerald J.L., and Reid J.J. Sympathomimetic actions of methylenedioxymethamphetamine in rat and rabbit isolated cardiovascular tissues. J. Pharm. Pharmacol. 46 (1994) 826-832
21. Foltin R.W., and Schuster C.R. Behavioural tolerance and cross-tolerance to dl-cathinone and d-amphetamine in rats. J. Pharmacol. Exp. Ther. 222 (1982) 126-131
22. Gordon C.J., Watkinson W.P., O'Callaghan J.P., and Miller D.B. Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat. Pharmacol. Biochem. Behav. 38 (1991) 339-344
23. Graser T., Leisner H., and Tiedt N. Absence of role of endothelium in the response of isolated coronary arteries to acetylcholine. Cardiovasc. Res. 20 (1986) 299-302
24. Griffiths P. Qat Use in London: a Study of Qat Use Among a Sample of Somalis Living in London. Home Office Drugs Prevention Initiative (1998), Home Office, London
25. Gugelmann R., Von Allmen M., Brenneisen R., and Portzig H. Quantitative differences in the pharmacological effects of (+) and (-) cathinone. Experientia 41 (1985) 1568-1571
26. Halket J.M., Karasu Z., and Murray-Lyon I.M. Plasma cathinone levels following chewing khat leaves (Catha edulis Forsk.). J. Ethnopharmacol. 49 (1995) 111-113
27. Harris D.S., Baggott M., Mendelson J.H., Mendelson J.E., and Jones R.T. Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology 162 (2002) 396-405
28. Henry J.A., Jeffries K.J., and Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstacy"). Lancet 340 (1992) 384-387
29. Itomine T., Matsuzaki T., Sakanashi M., Hobara N., and Saknashi M. β-Adrenoceptor blocking activities of nipradilol and its optical isomers in pig coronary artery. Clin. Exp. Pharmacol. Physiol. 28 (2001) 271-277
30. Kalant H. The pharmacology and toxicity of "ecstasy" (MDMA) and related drugs. CMAJ 165 (2001) 917-928
31. 3H]norepinephrine. Life Sci. 32 (1983) 801-807
32. Kalix P. The pharmacology of khat. Gen. Pharmacol. 15 (1984) 179-187
33. Kalix P. Cathinone, a natural amphetamine. Pharmacol. Toxicol. 70 (1992) 77-86
34. Kalix P., and Braenden O. Pharmacological aspects of the chewing of khat leaves. Pharmacol. Rev. 37 (1985) 149-164
35. Kohli J.D., and Goldberg L.I. Cardiovascular effects of (-)-cathinone in the anaesthetized dog: comparison with (+)-amphetamine. J. Pharm. Pharmacol. 34 (1982) 338-340
36. Kuchii M., Shibata S., and Mori J. Pharmacological nature of adrenergic innervation in rat aorta 1. Comp. Gen. Pharmacol. 4 (1973) 131-138
37. Landry M.J. MDMA: a review of epidemiology data. J. Psychoact. Drugs 34 (2002) 163-169
38. 2-adrenoceptor mediated actions of MDMA in rat atrium and vas deferens. Br. J. Pharmacol. 128 (1999) 975-980
39. Lester S.J., Baggott M., Welm S., Schiller N.B., Jones R.T., Foster E., and Mendelson J. Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial. Ann. Int. Med. 133 (2000) 969-973
40. 2-adrenoceptors in the anaesthetized rat. Br. J. Pharmacol. 133 (2001) 429-437
41. Maling H.M., Fleisch J.H., and Saul W.F. Species differences in aortic responses to vasoactive amines: the effects of compound 48-80, cocaine, reserpine and 6-hydroxydopamine. J. Pharmacol. Exp. Ther. 176 (1971) 672-683
42. Mas M., Farre M., De La Torre R., Roset P.N., Ortuno J., Segura J.A., and Cami J. Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans. J. Pharmacol. Exp. Ther. 290 (1999) 136-145
43. Milroy C.M., Clark J.C., and Forrest A.R.W. Pathology of deaths associated with "ecstasy" and "eve" misuse. J. Clin. Pathol. 49 (1996) 149-153
44. Myers P.R., Banitt P.F., Guerra R., and Harrison D.G. Role of endothelium in modulation of the acetylcholine vasoconstrictor response in porcine coronary microvessels. Cardiovasc. Res. 25 (1991) 129-137
45. Nichols D.E., Ilhan M., and Long J.P. Comparison of cardiovascular, hyperthermic and toxic effects of para-methoxyamphetamine (PMA) and 3,4-methylenedioxyamphetamine (MDA). Arch. Int. Pharmacodyn. Ther. 214 (1975) 133-140
46. O'Cain P.A., Hletko S.B., Ogden B.A., and Varner K.J. Cardiovascular and sympathetic responses and reflex changes elicited by MDMA. Physiol. Behav. 70 (2000) 141-148
47. 2 adrenoceptor-mediated responses in preparations of pulmonary artery and aorta from young and aged rats. J. Pharmacol. Exp. Ther. 228 (1984) 733-738
48. Ohgushi M., Vasue H., Kugiyama K., Murohara T., and Sakaino N. Contraction and endothelium-dependent relaxation via α-adrenoceptors are variable in various pig arteries. Cardiovasc. Res. 27 (1993) 779-784
49. Paton D.M. Effect of amphetamine, 3,4-methylenedioxymethamphetamine, p-methoxyamphetamine and related amphetamines on uptake of metaraminol and efflux of noradrenaline in adrenergic nerves of rabbit atria. J. Pharm. Pharmacol. 27 (1975) 361-362
50. Peroutka S.J., Newman H., and Harris H. Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology 1 (1988) 272-277
51. 2online)
52. Stanaszek W.F., Kellerman D., Brogden R.N., and Romankiewicz J.A. Prazosin update. A review of its pharmacological properties and therapeutic uses in hypertension and congestive heart failure. Drugs 25 (1983) 339-384
53. Weston A.H., Feletou M., Vanhoutte P.M., Falck J.R., Campbell W.B., and Edwards G. Bradykinin-induced, endothelium-dependent responses in porcine coronary arteries: involvement of potassium channel activation and epoxyeicosatrienoic acids. Br. J. Pharmacol. 145 (2005) 775-784
54. Widler P., Mathys K., Brenneisen R., Kalix P., and Fisch H.-U. Pharmacodynamics and pharmacokinetics of khat: a controlled study. Clin. Pharmacol. Ther. 55 (1994) 556-562
55. Yamada S., Yamazawa T., and Nakayama K. Direct binding and functional studies on muscarinic cholinoceptors in porcine coronary artery. J. Pharmacol. Exp. Ther. 252 (1990) 765-769
56. Zucchi R., Chiellini G., Scanlan T.S., and Grandy D.K. Trace amine-associated receptors and their ligands. Br. J. Pharmacol. (2006) 1-12 (advanced on-line publication)